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Abstract
Background: Adiposity is a modifiable factor that has been implicated in tendinopathy. As tendon pain reduces
physical activity levels and can lead to weight gain, associations between tendon pathology and adiposity must be
studied in individuals without tendon pain. Therefore, the purpose of this study was to determine whether fat
distribution was associated with asymptomatic Achilles tendon pathology.
Methods: The Achilles tendons of 298 individuals were categorised as normal or pathological using diagnostic
ultrasound. Fat distribution was determined using anthropometry (waist circumference, waist hip ratio [WHR]) and
dual-energy x-ray absorptiometry.
Results: Asymptomatic Achilles tendon pathology was more evident in men (13%) than women (5%) (p = 0.007). Men
with tendon pathology were older (50.9 ± 10.4, 36.3 ± 11.3, p < 0.001), had greater WHR (0.926 ± 0.091, 0.875 ± 0.065,
p = 0.039), higher android/gynoid fat mass ratio (0.616 ± 0.186, 0.519 ± 0.142, p = 0.014) and higher upper-body/lower
body fat mass ratio (2.346 ± 0.630, 2.022 ± 0.467, p = 0.013). Men older than 40 years with a waist circumference >83
cm had the greatest prevalence of tendon pathology (33%). Women with tendon pathology were older (47.4 ± 10.0,
36.0 ± 10.3, p = 0.008), had less total fat (17196 ± 3173 g, 21626 ± 7882 g, p = 0.009), trunk fat (7367 ± 1662 g,
10087 ± 4152 g, p = 0.003) and android fat (1117 ± 324 g, 1616 ± 811 g, p = 0.005). They had lower central/peripheral
fat mass ratios (0.711 ± 0.321 g, 0.922 ± 0.194 g, p = 0.004) than women with normal tendons. Women with tendon
pathology were more often menopausal (63%, 13%, p = 0.002).
Conclusions: Men with Achilles tendon pathology were older and had a central fat distribution. Women with
tendon pathology were older and had a peripheral fat distribution. An interaction between age and waist
circumference was observed among men.
Background
Achilles tendinopathy is a common injury and causes
pain during activities that place load on the Achilles
tendon – activities such as standing, walking, jogging
and running [1]. Not surprisingly, the condition is most
common among those with high levels of tendon load-
ing – 1 in every 2 runners will experience Achilles ten-
dinopathy before the age of 45 [2]. Surprisingly, people
with low levels of tendon loading are also frequently
affected – among the general community 1 in every 10
persons will be affected within their lifetime [2]. This
condition prevents individuals from participating in phy-
sical activity, precluding the benefits of physical activity
on health and obesity.
Treatment for Achilles tendinopathy can be lengthy
and frustrating [3], and, in the process, costly to the
individual and to the health system. As such, effective
prevention should be a priority. Identification of risk
factors is a critical first step in developing prevention
programmes. Recent evidence suggests that the amount
and distribution of adiposity may be a risk factor for
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change through diet and exercise interventions, this fac-
tor could potentially be incorporated into prevention
programmes.
A recent systematic review highlighted the association
between increased adiposity and tendinopathy [5]. This
review included all published papers addressing tendino-
pathy that also included a valid measurement of adipos-
ity. In 43% of cases, the group with tendinopathy had
significantly greater adiposity levels than the control
group without tendinopathy. Two other key findings of
that review are worth repeating. First, when upper-limb
and lower-limb tendinopathies were compared the asso-
ciation with adiposity was equally strong. As the lower-
limb tendons support body-weight while the upper-limb
tendons support only the weight of the limb, this finding
suggested that mechanical loading does not fully explain
the association between adiposity and tendinopathy. Sec-
ond, the longitudinal studies in the review that showed
baseline adiposity predicted tendinopathy at follow-up
suggested that adiposity is a risk factor for tendinopathy
rather than a consequence of tendinopathy.
Specifically, the data showed that the distribution of
adipose tissue is related to patellar tendon pathology in
lean male athletes [6] and lean female athletes [7], and
to medial elbow tendinopathy in male and female resi-
dents of Finland [8]. These studies suggest that a central
accumulation of adipose tissue is harmful to tendons.
Adding to this argument is the recent finding that indi-
viduals with painful mid-portion Achilles tendinopathy
display a dyslipidaemia characteristic of insulin resis-
tance [9]. As both dyslipidaemia and insulin resistance
are closely related to the expansion of intra-abdominal
(i.e. visceral) adipose tissue depots [10,11], precise mea-
surement of adipose tissue storage and exploration of its
association with Achilles tendon pathology is warranted.
Previous studies that have investigated adiposity and
symptomatic tendinopathy have not been able to avoid
the confounding effect of pain. Achilles tendon pain
leads to decreases in physical activity, and such reduc-
tions in physical activity are known to lead to increases
in adiposity [12,13]. Indeed, our findings show that 40%
of patients with Achilles tendinopathy report gaining
weight since their tendon first became painful, and
among this group their average estimated weight gain
was 5 kg (Gaida et al. unpublished data). To avoid this
confounding factor, all participants should be free from
pain when studying associations between adiposity and
Achilles tendon pathology. Diagnostic ultrasound can be
used to detect tendon pathology in individuals that have
no tendon pain [14]. Thus, the aim of this investigation
was to compare regional adipose tissue distribution
between members of the general community with
asymptomatic Achilles tendon pathology and those with
normal Achilles tendons. Our hypothesis was that a cen-
tral accumulation of adipose tissue would be related to
Achilles tendon pathology, and that the association
would be strongest in men.
Methods
Participants in this study were healthy and had no cur-
rent or previous symptoms of Achilles tendinopathy.
Pregnant or breast-feeding women were not eligible as
the study involved exposure to ionising radiation.
Women were asked to self report whether they were
pre-menopausal, peri-menopausal (≥ 1 menstrual cycle
in last 12 months) or post-menopausal (greater than
12 months since last menstrual cycle). Members of the
general population were invited to participate in this
study via advertisements posted in public locations and
through email contact. Participants were asked to for-
ward the details of the study to other potential partici-
pants. A university ethics committee approved the study
and all participants gave informed consent.
Data were collected with comparable methods from
two locations – Australia (97 men, 146 women) and Swe-
den (30 men, 25 women). Participants aged 18 to
75 years were eligible. To avoid bias, researchers measur-
ing anthropometric and fat-distribution variables were
unaware of the results of the ultrasound examination.
Anthropometry
T h es a m er e g i s t e r e da n t h r opometrist (JEG) measured
anthropometric variables in all participants (Australian
and Swedish) according to published protocols [15]. All
anthropometric variables were measured twice, with the
final result taken as the mean of the two measures. If
the measurement error exceeded 1%, a third measure-
ment was performed and the median value taken as the
final result.
A wall-mounted stadiometer (Australian Group –
[Heightronic 235; Measurement Concepts, North Bend,
Washington, USA], Swedish Group – [Harpenden Stadi-
ometer, Holtain Ltd, Crymych, Dyfed, UK]) was used to
record standing height to the nearest millimetre. Weight
was measured in light clothing and with shoes removed
using an electronic scale (Australian Group – [UC-321;
A&D Mercury Pty Ltd, Adelaide, South Australia, Aus-
tralia], Swedish Group – [HL 120, Avery Berkel, Smeth-
wick, UK]).
Waist circumference was measured using a flexible
steel tape (Lufkin W606PM; Cooper Hand Tools,
Raleigh, North Carolina, USA) against bare skin. Waist
circumference was measured to the nearest millimetre
in a horizontal plane at the midpoint between the iliac
crest and lower costal margin (palpated in the mid axil-
lary line). Repeated measurement of waist circumference
was performed on 20 subjects. The technical error of
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and the intra-class correlation coefficient (ICC) was cal-
culated at ICC(3,1) = 0.998. Hip circumference was
measured in a horizontal plane at the level of the great-
est posterior protuberance of the gluteal muscles as
viewed from the side. Repeated measurement of hip cir-
cumference was performed on 20 subjects. The TEM
for JEG was calculated at 0.29% and ICC(3,1) = 0.998.
Dual-Energy X-ray Absorptiometry
A trained and licenced bone densitometrist performed
full body scans using a dual-energy x-ray absorptiometer
(DXA) (Australian Group – [Lunar Prodigy (GE Lunar
Radiation Corporation, Madison, Wisconsin, USA) using
the multimedia version of EnCore software 8.10.027],
Swedish Group – [DPX-IQ (GE Lunar Radiation Cor-
poration, Madison, Wisconsin, USA) using Smart Scan
software version 4.7e]). Quality control was performed
d a i l yb e f o r es c a n n i n gt h ef i r s ts u b j e c tu s i n gap h a n t o m .
After acquisition, all scans were analysed in an identical
manner by a bone densitometrist who was blind to
group allocation. This study used standard DXA regions
of interest (ROI); arms, legs, trunk, android, gynoid.
The android ROI (Figure 1 – shown in blue) is represen-
tative of where many men preferentially store excess body
fat. The base of the android ROI sits immediately above
the pelvis and is equal in height to 20% of the distance
from the pelvis to the chin. The gynoid ROI (Figure 1 –
s h o w ni nr e d )i sr e p r e s e n t a t i v eo fw h e r em a n yw o m e n
preferentially store excess body fat. The android and
gynoid ROI are separated by a distance equal to 1.5 times
t h eh e i g h to ft h ea n d r o i dR O I ,w h i l et h eh e i g h to ft h e
gynoid ROI is double that of the android ROI.
As Australian and Swedish data were collected on differ-
ent machines, inter-machine reliability is critical. The
machine models used here have previously been cross-
validated and agree very closely (total body fat r
2 = 0.991)
[16]. The ROIs were defined using the same landmarks for
both machines. The repeatability of measurement on the
DPX-IQ (which does not automatically calculate
the android and gynoid ROIs) was determined by reanalys-
ing 20 scans (10 men, 10 women); android fat ICC(3,1) =
1.000 (95% CI 0.999 to 1.000), gynoid fat ICC(3,1) = 0.999
(95% CI 0.997 to 1.000).
In addition to standard ROIs, the pattern of adipose
tissue distribution was analysed. The android/gynoid fat
mass ratio, the upper-body/lower-body fat mass ratio
and the central/peripheral fat mass ratio were calculated.
Ultrasound
An experienced musculoskeletal radiologist (ZSK, Fellow
of the Royal Australian and New Zealand College of Radi-
ologists) performed all ultrasound examinations in the
Australian group (Acuson Aspen Advanced fitted with 5-
10 MHz linear array transducer; Siemens AG, Munich,
Germany). An experienced orthopaedic surgeon (HA) per-
formed all ultrasound examinations in the Swedish group
(Acuson Sequoia 512 fitted with 8-13 MHz linear array
transducer; Siemens AG, Munich, Germany).
The Achilles tendon was examined both longitudinally
and transversely to assess the overall structure, such as
internal fibre arrangement, blurring or irregularity of
tendon borders or bowing of the anterior border of the
tendon. During the longitudinal scan, care was taken to
ensure that the transducer was parallel to the tendon
fibres to avoid false positive findings (anisotropy) [17].
Each tendon was classified as having a normal or abnor-
mal internal structure. A tendon was classified as abnor-
mal if any of the three following conditions were met 1)
one or more focal hypoechoic regions visible in both the
longitudinal and transverse scans, 2) diffuse hypoecho-
genicity associated with bowing of the anterior tendon
border, or 3) diffuse hypoechogenicity associated with
generalised thickening of the tendon in comparison to
the contralateral tendon. Highly trained operators have
Figure 1 T y p i c a lf u l lb o d yD X As c a n . The android region of
interest (ROI) is highlighted in blue and the gynoid ROI is
highlighted in red (refer to text for the landmarks that define these
regions).
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or abnormal – (kappa = 1)[18,19]. Additionally, ultra-
sound is superior to MRI in classifying patellar tendon
structure when using an expert clinical diagnosis of
patellar tendinopathy as the gold standard [20].
The patellar and supraspinatus tendons were also
examined in the Australian participants using the same
methods. This data was used to examine whether having
an abnormal Achilles tendon was associated with
abnormality affecting other tendons.
Statistics
An ap r i o r idecision was made to analyse men and
women separately, as body composition is sexually
dimorphic [21]. Variables measured on a continuous
scale were tested for normality (Kolmogorov-Smirnov
test). Normally distributed variables were compared
between the groups (asymptomatic pathology versus
normal) using an unpaired t-test. If the assumption of
normality was violated, the Mann-Whitney U test was
used. Categorical variables were tested for group differ-
ences using the chi-square test.
A secondary analysis of the results was conducted
whereby a potential interaction between age and central
adiposity was explored. This consisted of a simple scat-
terplot of age versus waist circumference that was
divided into four groups. The data was first divided into
two groups according to whether an individual was ≤ 40
or > 40 years of age. This age has previously been used
to dichotomise data in tendinopathy research [22] and is
similar to the average age of men presenting with symp-
tomatic Achilles tendinopathy [23]. The data was next
divided using a waist circumference cut-off. In the men
this was guided by previous tendinopathy research [6],
which suggested a cut-off of 83 cm. In the lack of guid-
ing data from the tendinopathy literature for the
women, the cut-off of 80 cm was selected from the car-
diovascular literature. A waist circumference of 80 cm is
the designated action level 1 where no further weight
should be gain in order to minimised the risk of future
cardiovascular events [24]. Clustering of individuals with
Achilles tendon pathology into any of these four groups
was analysed using a chi-square analysis.
Results
Data was collected from 298 subjects - 127 men and 171
women (Table 1). Asymptomatic Achilles tendon
pathology was evident in more men (17/127, 13%) than
women (8/171, 5%) (c
2 = 7.189, df = 1, p = 0.007).
Men
Seventeen men had asymptomatic Achilles tendon
pathology; the remaining 110 men had normal Achilles
tendon structure. The men with pathology were older
than subjects with normal tendons (50.9 ± 10.4 years,
36.3 ± 11.3 years, p < 0.001). Those with pathology had
greater WHR (0.926 ± 0.091, 0.875 ± 0.065, p = 0.039),
higher android/gynoid fat mass ratio (0.616 ± 0.186,
0.519 ± 0.142, p = 0.014) and higher upper-body/lower
body fat mass ratio (2.346 ± 0.630, 2.022 ± 0.467,
p = 0.013) (Table 2).
Men with pathology in the Achilles tendon were no
more likely to have pathology of the patellar or rotator
cuff tendons (2/10 [20%], 11/87 [13%], p = 0.619)
(Table 2).
The scatterplot of age versus waist circumference
showed a clustering of men with abnormal tendons in the
group aged over 40 years and with a waist circumference
above 83 cm (c
2 = 19.13, df = 3, p < 0.001) (Figure 2). In
this group the prevalence of tendon pathology was 33%
(13/40) whereas in the other groups the prevalence was
between 2% and 10%.
Women
Eight women had asymptomatic Achilles tendon pathol-
ogy; the remaining 163 female subjects had normal
Achilles tendon structure. Women with Achilles tendon
pathology were older (47.4 ± 10.0, 36.0 ± 10.3, p = 0.008),
shorter (161.7 ± 6.1, 166.8 ± 6.6, p = 0.046), lighter (59.1
± 7.9, 66.2 ± 9.3, p = 0.048), and were more likely to be
peri/post-menopausal (5/8 [63%] versus 21/163 [13%],
p = 0.002) than subjects with normal tendons. There was
no difference in BMI between the groups (p = 0.319)
(Table 3).
In keeping with their lighter weight, the subjects with
abnormal Achilles tendons had less total fat [all measured
in grams] (17196 ± 3173, 21626 ± 7882, p = 0.009), trunk
fat (7367 ± 1662, 10087 ± 4152, p = 0.003) and android fat
(1117 ± 324, 1616 ± 811, p = 0.005). In contrast to the
men, the women with Achilles tendon pathology had
lower central/peripheral fat mass ratio (0.711 ± 0.321,
0.922 ± 0.194, p = 0.004) than women with normal ten-
dons (Table 3).
Women with Achilles tendon pathology were more
likely to have pathology affecting either the patellar or
supraspinatus tendon than women with normal Achilles
tendons (2/4 [50%], 7/142 [5%], p = 0.019) (Table 3).
The scatterplot of age versus waist did not show a clus-
tering of women with abnormal tendons into any
Table 1 Demographics (mean (SD)) of study participants.
Men
(n = 127)
Women
(n = 171)
Age (years) 38.3 (12.2) 36.5 (10.5)
Height (cm) 179.5 (6.8) 166.6 (6.7)
Weight (kg) 82.3 (11.0) 65.9 (9.3)
BMI (kg/m
2) 25.6 (3.5) 23.7 (3.2)
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2 = 5.375, df = 3, p = 0.1462) (Figure 3).
The prevalence of tendon pathology among the four
groups ranged from 0% to 11%.
Discussion
Tendon pathology has been shown to be associated with
fat distribution in two previous investigations; however,
in both cases the study group included participants who
were both symptomatic and asymptomatic [6,7]. As a
consequence these findings may have been affected by
altered physical activity behaviour secondary to tendon
pain. Using anthropometry and DXA this investigation
has shown that asymptomatic Achilles tendon pathology
was associated with unique patterns of adipose tissue
distribution but with quite different patterns in men and
women. The changes in fat distribution were associated
with tendon pathology in participants without a current
or recent history of tendon pain. This removed the con-
founding effect of tendon pain changing physical activity
behaviour and altering adiposity. As such, a strong case
is made for body composition playing a role in the
development of Achilles tendon pathology. This novel
finding increases our currently limited knowledge sur-
rounding the aetiology of Achilles tendinopathy.
Among the males in this cohort, despite no differences
in mean height, weight, BMI, waist or hip circumference
between the groups, the individuals with asymptomatic
Achilles tendon pathology had significantly elevated
WHR. This finding may be compared to that of Mal-
liaras et al. [6] who found significant differences
between WHR among three groupings of patellar ten-
don status – normal tendons, unilateral imaging changes
and bilateral imaging changes. The results of Malliaras
et al. agree with our findings, in that, the group with
normal tendons had the lowest WHR. The average
WHR ratio among those with normal tendons was
higher in our study (88.4 ± 9.8 cm Vs 79.1 ± 7.1 cm),
most likely attributable to Malliaras’ cohort being young
(26.1 ± 5.3 years) athletes.
In contrast, while Malliaras et al. [6] found men with a
waist circumference above 83 cm were much more
likely to have patellar tendon abnormality, in this inves-
tigation waist circumference did not differ according to
tendon status. However, individuals with asymptomatic
Achilles tendon pathology were significantly older than
those with normal tendons. This was the case for both
men (15 years older) and women (11 years older), and is
an aspect of the study that should be borne in mind
Table 2 Anthropometric and body composition (mean (SD)) comparison between men with and without tendon
pathology.
Normal Achilles
n = 110
Abnormal Achilles
n=1 7
p value
Age (years) 36.3 (11.3) 50.9 (10.4) <0.001
Anthropometry
Height (cm) 179.7 (6.9) 177.8 (6.3) 0.282
Weight (kg) 82.2 (10.9) 83.5 (11.8) 0.657
BMI (kg/m
2) 25.5 (3.5) 26.4 (3.2) 0.334
Waist (cm) 88.4 (9.8) 92.5 (11.6) 0.116
Hip (cm) 100.9 (6.1) 99.7 (4.5) 0.460
WHR‡ 0.875 (0.065) 0.926 (0.091) 0.039
Fat
Total (g) 18513 (8317) 20104 (7669) 0.460
Arms (g) 1543 (854) 1833 (856) 0.195
Leg (g) 5862 (2487) 5724 (1764) 0.826
Trunk (g) 10459 (5068) 11729 (5143) 0.339
Android (g) 1838 (987) 2084 (976) 0.341
Gynoid (g) 3385 (1340) 3303 (988) 0.808
Fat Mass Ratio
Android/Gynoid 0.519 (0.142) 0.616 (0.186) 0.014
Upper-body/Lower-body 2.022 (0.467) 2.346 (0.630) 0.013
Central/Peripheral‡ 1.393 (0.270) 1.533 (0.396) 0.176
Changes in other tendons (y:n)§ 11:76 2:8 0.619
† - Variable not normally distributed, Mann-Whitney U test.
‡ - Normally distributed but significant difference in variance between groups.
§ - Expected cell count < 5, Fisher’s Exact test.
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adiposity generally increases with age [25]. We exam-
ined the interaction between age and waist circumfer-
ence to explore these issues. Among the men there was
a clustering of those with abnormal tendons into the
group that was older than 40 years and with a waist cir-
cumference above 83 cm.
We found no difference in waist circumference or
WHR between women with asymptomatic Achilles ten-
don pathology and those with normal tendons, again in
agreement with data from Malliaras et al. [6]. This
implies that some transference of body composition
research is possible between the Achilles and the patel-
lar tendon. Similarity in underlying mechanisms may
account for the concordance of results [26]. Addition-
ally, there was no significant clustering of women with
abnormal tendons into any of the four groups con-
structed by the age and waist circumference cut-offs.
The men with abnormal Achilles tendons had higher
android/gynoid fat mass ratios as well as higher upper-
body/lower-body fat mass ratios. Expansion of adipose
tissue depots in the upper body and, in particular the
abdominal area, is associated with metabolic dysfunction
and increased cardiovascular risk [11,27,28]. As both
lipids and insulin resistance play a central role in this
relationship, recent findings associating dyslipidaemia
and Achilles tendinopathy [9] implicate abdominal fat in
the pathoaetiology of Achilles tendinopathy among
men. It is currently unclear whether this may occur
though the consequences of increased abdominal adip-
osity (i.e. dyslipidaemia or insulin resistance) or some
proximal factor that may contribute to abdominal fat
storage (i.e. genetics, diet, behaviour, lipid processing).
Paradoxically, the opposite findings were seen in the
women – those with tendon abnormality had lower cen-
tral/peripheral fat mass ratios. This finding is less likely
to be related to blood lipid or insulin resistance as an
underlying mechanism. A more likely explanation may
be related to the effect that oestrogen has on body fat
distribution. Among women, physiological levels of oes-
trogen prevent a central accumulation of adipose tissue.
Oestradiol – the main human oestrogen – has been
shown to inversely correlate with the central/peripheral
fat ratio measured by DXA [29]. Both endogenous [30]
and synthetic oestrogens [31,32] affect the function and
metabolism of tendons. However, the long-term effects
Figure 2 Scatter-plot of age and waist circumference in men. Men with normal tendons are indicated by blue triangles while men with
asymptomatic Achilles tendon pathology are indicated by green squares.
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don are incompletely understood [33]. As oestrogen was
not measured in this study we cannot speculate further,
although we did note that the majority (63%) of the
women with tendon pathology reported that they were
either peri-menopausal or post-menopausal (Table 3).
Limitations of the current research must be acknowl-
edged. First, data from two locations were pooled. Con-
founding was minimised by ensuring that data collection
was identical wherever possible, and that approximately
equal numbers of men and women as well as equal pro-
portions of cases and controls were recruited from each
location. Second, as all participants were asymptomatic
it is unclear how these results relate to the clinical con-
dition of Achilles tendinopathy. This is particularly per-
tinent given the complex relationship between tendon
pathology and tendon pain [34]. The inclusion of
asymptomatic participants was a deliberate action
designed to eliminate the confounding effect that pain
may have in modifying physical activity behaviour,
which would lead to weight gain and invalidate the
results. Third, although a large cohort was studied there
were relatively few cases with tendon pathology. This
limitation is a trade off related to the study design of
only including individuals with no tendon pain.
Strengths of this investigation should also be high-
lighted. First, neither the participants nor the research-
ers knew tendon status when the individual volunteered
for the study – thus selection bias was limited. Second,
during data collection personnel measuring anthropo-
metry and performing DXA were not aware of tendon
status. Third, this study was conducted in a large cohort
of both men and women. Fourth, the accurate DXA
technique was supplemented with inexpensive and read-
ily available anthropometric measurements.
Conclusion
In this large cohort, Achilles tendon pathology was asso-
ciated with unique fat patterning in both men and
women. Men with asymptomatic tendon pathology had
a central distribution of fat, while women with asympto-
matic tendon pathology had a peripheral distribution of
fat in comparison to their peers with normal tendons.
As all participants were free of tendon pain this is the
best evidence to date that differences in adipose tissue
distribution precede tendon pain.
Table 3 Anthropometric and body composition (mean (SD)) comparison between women with and without tendon
pathology.
Normal Achilles
n = 163
Abnormal Achilles
n=8
p value
Age (years)† 36.0 (10.3) 47.4 (10.0) 0.008
Menopause (pre:peri/post) 142:21 3:5 0.002
Anthropometry
Height (cm) 166.8 (6.6) 161.7 (6.1) 0.046
Weight (kg) 66.2 (9.3) 59.1 (7.9) 0.048
BMI (kg/m
2) 23.8 (3.2) 22.6 (2.6) 0.319
Waist (cm) 77.0 (8.8) 75.2 (5.3) 0.596
Hip (cm) 100.4 (6.8) 95.6 (6.9) 0.065
WHR‡ 0.766 (0.065) 0.789 (0.064) 0.367
Fat
Total (g)‡ 21626 (7882) 17196 (3173) 0.009
Arms (g) 1957 (882) 1673 (423) 0.399
Leg (g) 8897 (3058) 7436 (1484) 0.211
Trunk (g)‡ 10087 (4152) 7367 (1662) 0.003
Android (g)‡ 1616 (811) 1117 (324) 0.005
Gynoid (g) 4719 (1359) 3815 (638) 0.082
Fat Mass Ratio
Android/Gynoid 0.330 (0.107) 0.298 (0.098) 0.449
Upper-body/Lower-body 1.346 (0.313) 1.229 (0.237) 0.330
Central/Peripheral 0.922 (0.194) 0.711 (0.321) 0.004
Changes in other tendons (y:n)§ 7:135 2:2 0.019
† - Variable not normally distributed, Mann-Whitney U test.
‡ - Normally distributed but significant difference in variance between groups.
§ - Expected cell count < 5, Fisher’s Exact test.
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Achilles tendinopathy is a difficult to treat condition
that presents not only in athletes but also in sedentary
individuals. Cases in non-athletic individuals remain
hard to explain through biomechanical theories. A cen-
tral distribution of body fat has been linked with symp-
tomatic patellar and lateral elbow tendinopathy. A
limitation of these studies is that tendon pain may
reduce physical activity and lead to weight gain, con-
founding the results. Studying asymptomatic populations
and using ultrasound to define tendon status can avoid
this limitation. Data addressing body fat distribution in
relation to the Achilles tendon is lacking.
What this study adds
Among a large cohort, this study showed that body fat
distribution differed according to tendon status in
asymptomatic participants. The men with tendon
pathology showed a central distribution of body fat con-
sistent with our hypothesis. By contrast, the women
with tendon pathology had a peripheral distribution of
body fat. An interaction between age and waist
circumference was observed among men – the highest
prevalence of tendon pathology was among men older
than 40 years and with a waist circumference >83 cm.
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